Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Vemurafenib MeSH Descriptor Data 2025


MeSH Heading
Vemurafenib
Tree Number(s)
D02.065.884.919
D02.886.590.700.919
D03.633.100.473.936
Unique ID
D000077484
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077484
Scope Note
An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA.
Entry Term(s)
PLX 4032
PLX4032
R05185426
RG-7204
RG7204
Zelboraf
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Numbers
207SMY3FQT
0
CAS Type 1 Name
1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-
Public MeSH Note
2019; VEMURAFENIB was indexed under INDOLES and SULFONAMIDES 2010-2018
History Note
2019 (2010)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/04/09
Vemurafenib Preferred
PLX4032 Narrower
Zelboraf Narrower
R05185426 Narrower
RG7204 Narrower
page delivered in 0.141s